What is the analyst consensus rating for NBIX?

The analyst consensus rating for NBIX is "Buy" based on 28 analyst recommendations.

What is the average price target for NBIX?

The average 12-month price target for NBIX is $190.60, representing an upside of 18.1% from the current price of $161.44.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Neurocrine Biosciences, Inc. (NBIX) Forecast: Analyst Ratings & Targets

Latest NBIX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Jun 16, 2026	Unknown Analyst	Jefferies	Maintains	Buy	$181.00
Jun 16, 2026	Yigal Nochomovitz	Citi	Maintains	Buy	$246.00
Jun 2, 2026	Myles Minter	William Blair	Reiterates	Buy	-
Jun 2, 2026	Corinne Johnson	Goldman Sachs	Initiates	Buy	$213.00
May 29, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Buy	$185.00 → $184.00 -1.00 (-0.5%)
May 29, 2026	Brian Abrahams	RBC Capital	Maintains	Buy	$180.00 → $183.00 +3.00 (1.7%)
May 21, 2026	Jeffrey Walch	Bernstein	Initiates	Buy	$221.00
May 18, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$210.00
May 11, 2026	Evan Seigerman	BMO Capital	Maintains	Hold	$144.00
May 11, 2026	Ami Fadia	Needham	Reiterates	Buy	$200.00
May 8, 2026	Anupam Rama	JP Morgan	Initiates Coverage	Buy	$177.00 → $185.00 +8.00 (4.5%)
May 7, 2026	Danielle Brill	Truist	Initiates Coverage	Buy	$155.00
May 7, 2026	David Hoang	Deutsche Bank	Maintains	Hold	$150.00 → $155.00 +5.00 (3.3%)
May 6, 2026	Paul Matteis	Stifel Nicolaus	Maintains	Buy	$188.00
May 6, 2026	Sumant Kulkarni	Canaccord Genuity	Reiterates	Buy	$200.00
May 6, 2026	David Amsellem	Piper Sandler	Reiterates	Buy	$190.00 → $207.00 +17.00 (8.9%)
May 6, 2026	Jay Olson	Oppenheimer	Initiates Coverage	Buy	$220.00 → $230.00 +10.00 (4.5%)
May 6, 2026	Sean Laaman	Morgan Stanley	Reiterates	Hold	$185.00 → $191.00 +6.00 (3.2%)
May 5, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	$200.00
May 4, 2026	Andrew Fein	HC Wainwright	Maintains	Buy	$215.00
Apr 22, 2026	Marc Goodman	Leerink Partners	Maintains	Buy	$160.00 → $170.00 +10.00 (6.3%)
Apr 21, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Apr 15, 2026	Tazeen Ahmad	BofA Securities	Maintains	Buy	-
Apr 10, 2026	Jeffrey Hung	Morgan Stanley	Maintains	Hold	$173.00 → $185.00 +12.00 (6.9%)
Apr 7, 2026	Sumant Kulkarni	Canaccord Genuity	Maintains	Strong Buy	$164.00 → $200.00 +36.00 (21.9%)
Apr 7, 2026	Laura Chico	Wedbush	Maintains	Buy	$151.00 → $166.00 +15.00 (9.9%)
Apr 7, 2026	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$192.00 → $215.00 +23.00 (12.0%)
Apr 7, 2026	Yigal Nochomovitz	Citi	Maintains	Strong Buy	$204.00 → $242.00 +38.00 (18.6%)
Apr 6, 2026	Ashwani Verma	UBS	Maintains	Buy	$161.00
Apr 6, 2026	Rudy Li	Wolfe Research	Reiterates	Buy	$160.00
Apr 6, 2026	Ami Fadia	Needham	Reiterates	Strong Buy	$185.00 → $185.00 +0.00 (0.0%)

Unknown Analyst

Jefferies

BuyMaintains

$181.00

Jun 16

Yigal Nochomovitz

Citi

BuyMaintains

$246.00

Jun 16

Myles Minter

William Blair

BuyReiterates

Jun 2

Corinne Johnson

Goldman Sachs

BuyInitiates

$213.00

Jun 2

OpenAI Biotechnology

TipRanks - OpenAI

BuyReiterates

$185.00 → $184.00

May 29

Brian Abrahams

RBC Capital

BuyMaintains

$180.00 → $183.00

May 29

Jeffrey Walch

Bernstein

BuyInitiates

$221.00

May 21

Cory Kasimov

Evercore ISI Group

BuyMaintains

$210.00

May 18

Evan Seigerman

BMO Capital

HoldMaintains

$144.00

May 11

Ami Fadia

Needham

BuyReiterates

$200.00

May 11

Anupam Rama

JP Morgan

BuyInitiates Coverage

$177.00 → $185.00

May 8

Danielle Brill

Truist

BuyInitiates Coverage

$155.00

May 7

David Hoang

Deutsche Bank

HoldMaintains

$150.00 → $155.00

May 7

Paul Matteis

Stifel Nicolaus

BuyMaintains

$188.00

May 6

Sumant Kulkarni

Canaccord Genuity

BuyReiterates

$200.00

May 6

David Amsellem

Piper Sandler

BuyReiterates

$190.00 → $207.00

May 6

Jay Olson

Oppenheimer

BuyInitiates Coverage

$220.00 → $230.00

May 6

Sean Laaman

Morgan Stanley

HoldReiterates

$185.00 → $191.00

May 6

Phil Nadeau

TD Cowen

BuyMaintains

$200.00

May 5

Andrew Fein

HC Wainwright

BuyMaintains

$215.00

May 4

Marc Goodman

Leerink Partners

BuyMaintains

$160.00 → $170.00

Apr 22

Zacks Equity Research

BuyInitiates Coverage

Apr 21

Tazeen Ahmad

BofA Securities

BuyMaintains

Apr 15

Jeffrey Hung

Morgan Stanley

HoldMaintains

$173.00 → $185.00

Apr 10

Sumant Kulkarni

Canaccord Genuity

Strong BuyMaintains

$164.00 → $200.00

Apr 7

Laura Chico

Wedbush

BuyMaintains

$151.00 → $166.00

Apr 7

Andrew S. Fein

HC Wainwright

Strong BuyMaintains

$192.00 → $215.00

Apr 7

Yigal Nochomovitz

Citi

Strong BuyMaintains

$204.00 → $242.00

Apr 7

Ashwani Verma

UBS

BuyMaintains

$161.00

Apr 6

Rudy Li

Wolfe Research

BuyReiterates

$160.00

Apr 6

Ami Fadia

Needham

Strong BuyReiterates

$185.00 → $185.00

Apr 6

Neurocrine Biosciences, Inc. (NBIX) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest NBIX Analyst Ratings & Recommendations

Frequently Asked Questions